Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Figures corrected NBB
Corrected annual account filed for 2024.
-
Busy address KBO
12 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
Fondation Charcot-Vaincre la sclérose en plaques from Schaarbeek, company number BE0468831484, closed financial year 2025 with a result of € 467,137 after tax. For that financial year Fondation Charcot-Vaincre la sclérose en plaques recorded a gross margin of € 392,269 and equity of € 3.1 million. Compared with financial year 2024, the result moved from € -584,345 to € 467,137. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 9, 2026.
€ 3.1 million
▲ 19% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 467,137
▲ still € 584,345 loss in 2024
Profit after tax over the fiscal year.
€ 1.4 million
▲ € 1.1 million vs 2024
Cash and bank balances on the last day of the fiscal year.
People and assets in 2025
1.2
▼ 0.3 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 78,625
▼ 13% vs 2024
€ 65,500 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 1,303
▼ 45% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 20,765
▼ 67% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 9,948
▼ 21% vs 2024
Wages, holiday pay and social contributions still to pay. No outstanding taxes.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € -182,328 | € -416,166 | € -631,445 | € 392,269 | ▲ € 1 million |
| Profit after taxes | € -365,801 | € -568,313 | € -584,345 | € 467,137 | ▲ € 1.1 million |
| Equity | € 3,735,288 | € 3,166,975 | € 2,582,630 | € 3,064,031 | ▲ 19% |
| Total debts | € 91,847 | € 117,097 | € 109,106 | € 100,010 | ▼ 8% |
| Cash | € 1,007,861 | € 501,528 | € 280,601 | € 1,356,681 | ▲ € 1.1 million |
| Retained profit | € 3,035,288 | € 2,466,975 | € 1,882,630 | € 2,349,767 | ▲ 25% |
| Balance sheet total | € 3,827,135 | € 3,284,072 | € 2,691,735 | € 3,164,042 | ▲ 18% |
| Employees (FTE) | 1.9 | 1.5 | 1.5 | 1.2 | ▼ 0.3 |
Key figures of Fondation Charcot-Vaincre la sclérose en plaques, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Fondation Charcot-Vaincre la sclérose en plaques?
What happened at Fondation Charcot-Vaincre la sclérose en plaques in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Lorette Rousseau stepped down as director. NBB
- Baron Pierre Paulus de Châtelet stepped down as director. NBB
- Bénédicte Dubois stepped down as director. NBB
- Charles-Henri Maus de Rolley stepped down as director. NBB
- Patrik Cras stepped down as director. NBB
- Isabelle Bloem - Gonsette stepped down as director. NBB
- Pierre Coulie stepped down as director. NBB
- Sarah Laurent stepped down as director. NBB
In short
From € 365,801 loss in 2022 to € 467,137 profit in 2025.
Best year ever: 2025, with € 467,137 profit.
On average € 326,900 of value added per employee in 2025.
A new publication or filing at Fondation Charcot-Vaincre la sclérose en plaques? We notify you, reason included.
Follow Fondation Charcot-Vaincre la sclérose en plaquesDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Directors
According to the 2025 annual accounts
Pierre Coulie
Director
Also active at: ASSOCIATION BELGE CONTRE LE CANCER, Université des Aînés, OEUVRE BELGE DU CANCER, FEDERATION BELGE CONTRE LE CANCER-BELGISCHE FEDERATIE TEGEN KANKER-BELGISCHE FÖDERATION GEGEN KREKS-BELGIAN FEDERATION AGAINST CANCER, FONDATION CONTRE LE CANCER
since 2025 · until 2028
Lorette Rousseau
Director
since 2015 · until 2030
since 2025 · until 2028
Vincent Van Pesch
Director
since 2025 · until 2028
Jérôme Van Der Bruggen
Director
since 2022 · until 2027
Baron Pierre Paulus de Châtelet
Director
since 2005 · until 2030
Bénédicte Dubois
Chairman of the board
since 2015 · until 2030
Vincent Vliebergh
Director
Also active at: SOIL CAPITAL BELGIUM, Highland Life Sciences, Hauteterre CS, Edaphon, Edateam, mazerine Partners, Korys Capital GP
since 2022 · until 2027
Charles-Henri Maus de Rolley
Vice-chairman of the board
Also active at: BESIDE YOU, Edaphon, Edateam
since 2005 · until 2030
since 2025 · until 2028
Patrik Cras
Director
since 2005 · until 2030
Isabelle Bloem - Gonsette
Managing director
since 2010 · until 2030
Establishments
Establishment units
Physical locations of this company
Huart Hamoirlaan 48
1030 Schaarbeek
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 12 companies are registered at this address.
All companies at this address →Belgische Studiegroep voor Multiple Sclerose
SOLIDARITY NNM
DICANNO
€ -66 gross margin · 2025
Africa Women Promotion
MED ALL SOLUTION
€ -129 gross margin · 2025
+7 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Microsoft 365
Hosting
CLOUDFLARESPECTRUM Cloudflare, Inc., US
Domain
Domain
fondation-charcot.org
Registered
1999-06-28
Registrar
EuroDNS S.A.
Expires
2026-06-28
Website info
Features
Security
Details
- Company number
- 0468.831.484
- VAT number
- BE 0468.831.484
- Registered office
- Huart Hamoirlaan 48, 1030 Schaarbeek
- Names & denominations
- Fondation Charcot-Vaincre la sclérose en plaques · Fondation Charcot · Charcot Stichting - Multiple Sclerose Overwinnen
- Enterprise type
- Rechtspersoon
- Legal form
- Public-interest foundation
- Legal situation
- Normale toestand
- Start date
- 9 June 1999
- Peppol
- Active · Active since 22 Dec 2025
- Activities · NACE
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied